Reinhard Dummer

103PUBLICATIONS

525CO-AUTHORS

Predictive and prognostic markersTumour immunologyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Adolescent health

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (103)

Sort by Publication Date:

|Jul 02, 2026

Years of life lost in patients with a false-negative diagnosis of primary melanoma. A prospective study of the German Central Malignant Melanoma Registry involving 9063 patients over 28 years.

|Jun 09, 2026

Depicting the Immunological Landscape of Basal Cell Carcinoma Subtypes.

|May 13, 2026

Early ctDNA Dynamics Predict Response to Mosperafenib in BRAF V600-Mutant Metastatic Colorectal Cancer.

|May 04, 2026

Discontinuation of combo immunotherapy and outcome of patients with melanoma brain metastases.

|Mar 28, 2026

Advantages of MelArray over Oncomine Focus Assay for Mutation Analysis in Melanoma.

Andrew E Quacoe, Sandra N Freiberger, Mitchell P Levesque

|Mar 27, 2026

Phase I Study of Mosperafenib, a Novel Paradox Breaker B-Raf Proto-Oncogene Serine/Threonine Kinase (BRAF) Inhibitor, in Patients With <i>BRAF</i> V600-Mutant Solid Tumors.

Maria Vieito, Elisa Fontana, Catherine H Han

Pageof 18

Frequent Collaborators

23 joint publications

Mitchell Paul Levesque

22 joint publications

Paolo Antonio Ascierto

15 joint publications

Egle Ramelyte

14 joint publications

Phil Fang Cheng

14 joint publications

Dirk Schadendorf

12 joint publications

Georgina V Long

11 joint publications

Caroline Robert

8 joint publications

Piotr Rutkowski

8 joint publications

Claus Garbe

8 joint publications

Patrick Turko

Frequent Collaborators

23 joint publications

Mitchell Paul Levesque

22 joint publications

Paolo Antonio Ascierto

15 joint publications

Egle Ramelyte

14 joint publications

Phil Fang Cheng